文献速递神经MR

胶质母细胞瘤中的孤立性弥散受限:发生率、进展及对生存的影响

Isolated restricted diffusion in glioblastoma: incidence, progression, and survival impact '.
PubMed 文献 · Neuroradiology · 2025-07-08

前瞻性初步队列研究纳入52例疑似胶质母细胞瘤的成人患者,21%(11/52)存在孤立性弥散受限(IRD),两名阅片者诊断IRD的一致性为一般(kappa=0.29);11例IRD患者中仅7例(64%)在中位随访110天时IRD病灶出现强化,Kaplan-Meier分析显示IRD患者生存显著缩短(p=0.035)。

要点

  • 胶质母细胞瘤患者中约21%可见孤立性弥散受限(IRD),即强化灶外无强化的弥散受限区。
  • IRD病灶随访中约64%出现强化,中位随访时间110天。
  • IRD患者生存期显著缩短(p=0.035),阅片时需关注强化灶外的弥散受限区。

核心结论

  • 胶质母细胞瘤患者中IRD发生率为21%,其中64%在随访影像上出现强化,IRD病灶与较短生存相关。

研究设计与样本

  • 前瞻性初步队列研究,连续纳入52例≥18岁、初诊MRI怀疑胶质母细胞瘤的成人患者,由两名经验丰富的放射科医生独立分析图像评估阅片者间信度,采用Cox回归和Kaplan-Meier曲线分析IRD患者的生存模式。

关键影像表现/征象

  • IRD定义为强化肿瘤范围外、增强扫描无相应强化的弥散受限区。
  • 52例患者中11例(21%)存在IRD病灶。
  • 两名阅片者诊断IRD的一致性为一般(kappa=0.29)。
  • 11例IRD患者中7例(64%)在中位随访110天时IRD病灶出现强化。

诊断标准与关键数值

  • IRD诊断标准:弥散受限位于强化肿瘤范围之外,且增强扫描无相应强化。
  • 两名阅片者诊断IRD的kappa=0.29。
  • IRD患者生存分析Kaplan-Meier显示生存显著下降(p=0.035)。

临床应用与阅片要点

  • 阅片时应评估强化灶外是否存在孤立性弥散受限区,并注意两名阅片者间一致性仅为一般(kappa=0.29)。
  • 对检出IRD的患者,随访影像中约64%的病灶在中位110天出现强化,提示需关注IRD病灶的强化进展。
  • IRD病灶与较短生存相关(p=0.035),可在报告中提示其存在。

局限性

  • 原文为前瞻性初步队列研究(pilot cohort study)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Glioblastoma (GB) is the most malignant primary brain tumor. Isolated restricted diffusion (IRD) is restricted diffusion outside the confines of enhancing tumor with no corresponding enhancement on post contrast study. The aim of our study was to prospectively assess the incidence of IRD in GB patients, determine how often these foci proceed to contrast enhancement on follow up, and analyze the survival pattern of patients with IRD.

METHODS: In a prospective pilot cohort study, consecutive adult patients (≥ 18 years old) suspected of having GB on initial MRI of brain, were included and screened for the presence of IRD. All images were independently analyzed by two experienced radiologists for inter-rater reliability. The survival pattern of patients with IRD was assessed with Cox-regression and Kaplan-Meier curve analysis.

RESULTS: Of the 52 patients (median age- 63 years; male-63.5%) included, 21% (11 of 52) exhibited foci of IRD. Inter-rater agreement on the diagnosis of IRD foci was fair (kappa = 0.29) between the two readers. Among the 11 patients with IRD, only 7 (64%) showed enhancement in the IRD focus on imaging at a median follow up time of 110 days. The Kaplan Meier analysis revealed a significant decrease (p = 0.035) in the survival among patients with IRD focus.

CONCLUSION: In conclusion, IRD foci were seen in 21% of patients with GB, with 64% of these demonstrating enhancement at the IRD focus on follow up imaging. A shorter survival was associated with IRD foci.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Shankar J, Patil N, Ayroso M, et al. Isolated restricted diffusion in glioblastoma: incidence, progression, and survival impact '. Neuroradiology. 2025. PMID: 40627192. doi:10.1007/s00234-025-03672-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。